[Susceptibility of Branhamella catarrhalis to antibiotics].
A total of 98 isolates of Branhamella catarrhalis were examined for their susceptibility to antibiotics using serial dilution method. Nitrocefin test was employed for detection of beta-lactamase activity. It was found that most of the isolates (71%) were resistant to ampicillin. Resistance to this antibiotic was accompanied by ability to beta-lactamase production. On the other hand, all isolates were susceptible to amoxicillin + clavulanic acid combination. Almost all isolates were susceptible to cefaclor (99%), cefuroxime (94%), cefotaxime (100%), ciprofloxacin (100%), tetracycline (91%), cotrimoxazole (93%) and erythromycin (93%).
Leszczyńska
Katarzyna
K
Zakład Diagnostyki Mikrobiologicznej Akademia Medyczna w Białymstoku.
Jakoniuk
Piotr
P
Sacha
Paweł Tomasz
PT
Zalewska
Marta
M
Wieczorek
Piotr
P
D000658:Amoxicillin / Q000494:pharmacology; D000667:Ampicillin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002433:Cefaclor / Q000494:pharmacology; D002439:Cefotaxime / Q000494:pharmacology; D002444:Cefuroxime / Q000494:pharmacology; D002939:Ciprofloxacin / Q000494:pharmacology; D002969:Clavulanic Acids / Q000494:pharmacology; D004338:Drug Combinations; D004917:Erythromycin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D001936:Moraxella catarrhalis / Q000187:drug effects* / Q000201:enzymology; D013752:Tetracycline / Q000494:pharmacology; D001618:beta-Lactamases / Q000096:biosynthesis*
D000900:Anti-Bacterial Agents; D002969:Clavulanic Acids; D004338:Drug Combinations; D002939:Ciprofloxacin; D004917:Erythromycin; D002433:Cefaclor; D000667:Ampicillin; D000658:Amoxicillin; D001618:beta-Lactamases; D013752:Tetracycline; D002439:Cefotaxime; D002444:Cefuroxime